Pioneering sophisticated technologies for
sleep disorders &
movement disorders
to improve the quality of life for people around the world.
1.877.CLEVEMED (1.877.253.8363)
1.877.CLEVEMED (1.877.253.8363)
CleveMed News Releases
For More Information Contact:
Maureen PhillipsCleveland Medical Devices Inc.
P: 216.791.6720
mphillips@clevemed.com
www.clevemed.com
FOR IMMEDIATE RELEASE
JOSEPH GIUFFRIDA, PHD APPOINTED TO CLEVEMED VICE PRESIDENT, GENERAL MANAGER
Cleveland, Ohio (September 9, 2009) - Cleveland Medical Devices Inc. (CleveMed) has announced the promotion of Joseph P. Giuffrida, PhD to Vice President, General Manager of the Division of Movement Disorders. As CleveMed continues to expand as a medical device company, Dr. Giuffrida will continue filling a crucial role to assist with the company’s continued growth.
Dr. Giuffrida, 33, completed his BS, MS and PhD in Biomedical Engineering at Case Western Reserve University with a concentration in rehabilitation engineering. He began his career at CleveMed in 2000 as an Applications Engineer and upon receipt of his PhD in 2004, became a Principal Investigator and eventually Director of the Division of Movement Disorders. Within these roles, Dr. Giuffrida has secured over $8 million in funding from both the National Institutes of Health and the State of Ohio to fuel the research, development, and commercialization of innovative medical devices focused on aiding in the diagnosis and therapy of movement disorders. He has secured FDA clearance to market for a number of CleveMed systems, managed reimbursement strategies for new and emerging technology, established multiple world renowned key opinion leaders and clinical consultants, and lead the marketing and sales teams for CleveMed’s clinical movement disorder products as well as the research and education product lines.
Most notably, CleveMed’s Division of Movement Disorders commercialized and launched Kinesia under Dr. Giuffrida’s direction. This technology is intended to provide a standardized platform for objectively quantifying motor symptoms associated with Parkinson’s disease. Additional research and development in this Division is focused on extending the market applications for Kinesia from clinical office visits to home monitoring and deep brain stimulation programming, assistive technologies to aid in communication for persons with limited mobility and speech impairment and the development of rehabilitation systems to aid in motor recovery after brain injuries such as stroke or cerebral palsy.
In addition to the Division of Movement Disorders, Dr. Giuffrida also manages CleveMed’s line of products focused on the research and education market. Dr. Giuffrida was able to commercialize CleveMed’s wireless physiological monitoring technology into specific academic and university based target applications to increase CleveMed’s sales both domestically and internationally.
"Joe has been a crucial part of our success and we are thrilled to promote him to this vital position" said Hani Kayyali, President. "He will continue to grow our role as a pioneer in the area of Parkinson’s disease monitoring and movement disorders research to new levels".
About CleveMed
CleveMed was founded with the goal of developing innovative telemetry devices for a variety of medical applications. Today, CleveMed is developing and pioneering the use of novel wireless monitoring systems for high growth neurology and rehabilitation applications, including movement disorders and sleep disorders. Through these innovations, CleveMed has developed a growing range of products that address the needs of the medical, research and academic communities. For more information, please visit www.CleveMed.com
